Asston Pharmaceuticals IPO GMP, Overview, Listing, And Allotment By Finowings

Check the latest Asston Pharmaceuticals IPO GMP, price band, lot size, allotment, and listing date. Read a detailed IPO analysis and market insights on Finowings to make informed investment decisions.



Asston Pharmaceuticals IPO GMP – Complete Details at a Glance

Company Introduction


Asston Pharmaceuticals Limited is an emerging pharmaceutical company, founded in 2019. The company manufactures a wide range of medicines such as tablets, capsules, syrups, sachets, and creams, and supplies these to domestic as well as international markets. The company is also active in the field of nutraceuticals and operates on a contract manufacturing model for several products.

 Asston Pharmaceuticals IPO GMP


Asston Pharmaceuticals IPO GMP remains a key discussion topic among investors. The grey market premium (GMP) indicates how much premium the company's shares are getting in the unofficial market before listing.


Day 1 (on the day of IPO opening): GMP around ₹10

 Day 2: GMP rose to ₹30, indicating that investors have positive sentiments about the IPO.


This makes it likely that the company's listing price may be significantly higher than the issue price.


 IPO Overview


 IPO Type: SME IPO (Book-built issue)

 Issue Size: ₹27.56 crore (Total 22.41 lakh shares)

 Face Value: ₹10 per share

 Price Band: ₹115 to ₹123 per share

 Lot Size: 1000 shares

 Minimum Investment (Retail): ₹2,46,000 (2 lots 2000 shares)

 HNI Investment: Minimum 3 lots  ₹3,69,000


 Asston Pharmaceuticals IPO Timeline


Below is the complete timeline of Asston Pharmaceuticals IPO (as available in Finowings is):


 IPO Opening Date: 09 July 2025

 IPO Closing Date: 11 July 2025

 Share Allotment Date: 14 July 2025

 Refund Start Date: 15 July 2025

 Share Credit in Demat Account: 15 July 2025

 Listing Date (Expected): 16 July 2025


 Financial Performance


The company has shown tremendous growth in the last few years. In FY2025:

 Revenue: ₹25.61 crore — nearly 60% YoY growth

 Net Profit (PAT): ₹4.32 crore — over 200% growth

This performance is a reliable signal for investors.


Use of Funds (Objects of the Issue)


The company will use the funds raised from the IPO for the following purposes:


 Purchase of new machinery for the manufacturing unit

 Meeting working capital requirements

 Repayment of certain debts

 For general corporate needs


Lead Manager and Registrar


 Lead Manager: Sobhagya Capital Options Limited

 Registrar: Maashitla Securities Private Limited

 Market Maker: JSK Securities and Services Private Limited


Conclusion


The current status of Asston Pharmaceuticals IPO GMP indicates that investors are positive about it. Strong financials, clear fund utilization, and accurate price band make this an attractive SME IPO. Although the SME segment is volatile, growth-oriented investors can look at this as an opportunity.

Comments

Popular posts from this blog

Ganga Bath Fitting IPO GMP: Price, Dates, and Key Insights

Aaradhya Disposal IPO GMP, Date, Price, Allotment, and Details

Ganga Bath Fittings IPO GMP Today, Price, Review & Details 2025